Page 7 - Mitchell Warren News Today

Cabotegravir is a promising HIV prevention medication that’s approved in countries like the United States. But in sub-Saharan Africa, access encounters a number of hurdles.

South Africa’s medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days. If the shot is approved, the health department could start rolling it out on a large scale within nine months — but that depends on the injection’s price.

But not if people can't get it

South Africa's medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days. If the shot is approved, the health department could start rolling it out on a large scale within nine months - but that depends on the injection's price.

Thabo Molelekwa asked several experts what behaviour change communications should look like in this new era of HIV prevention.

South Africa’s medicines regulator will announce a decision on the approval of a two-monthly HIV prevention jab within days.

Dear colleagues, Like many of you, we are looking forward to being together at the International Conference on Family Planning in Pattaya, Thailand in just a few weeks. We are eager for the opportunities to learn from one another, to find opportunities to work together and to share in our successes. FP2030 is looking forward to celebrating and amplifying dozens of new FP2030

SOWETO, South Africa — For seven years, a daily pill has been available in South Africa to protect people from getting HIV. But when Victoria Makhandule, a community health...

An injection every two months rather than a daily pill could shield many more women from the virus, but it is unavailable in places that need it most.

CAB-LA injections offer stigma-free protection for those at risk – particularly women in Africa. A deal with pharmaceutical companies is crucial